Cardiovascular disease is the most common cause of death in the world. In severe cases,
replacement or revascularization using vascular grafts are the treatment options. While …

Background Polymer-free drug-coated stents provide superior clinical outcomes to bare-
metal stents in patients at high bleeding risk who undergo percutaneous coronary …

comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Abstract Background: The FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …

Aims The value of elective coronary revascularisation plus medical therapy over medical
therapy alone in managing stable patients with coronary artery disease is debated. We …

For 20 years, dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a
platelet P2Y12 receptor inhibitor, has been the gold standard of antithrombotic …

Background: Although guidelines recommend in-hospital initiation of high-intensity statin
therapy in patients with acute coronary syndromes (ACS), low-density lipoprotein cholesterol …

Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …

Abstract Aims The SYNTAX II study evaluated the impact of advances in percutaneous
coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes …

Abstract The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented
challenge to healthcare worldwide. The infection can be life threatening and require …